+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Biological Valve Market - Global Forecast 2025-2030- Product Image
Artificial Biological Valve Market - Global Forecast 2025-2030- Product Image
Sale

Artificial Biological Valve Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6116933
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The artificial biological valve market is undergoing swift transformation, propelled by technological innovation, shifting clinical practices, and evolving regulatory landscapes. Senior decision-makers are confronted with rising demand, new patient profiles, and complex trade policies, making actionable market intelligence a necessity for sustained competitiveness.

Market Snapshot: Growth and Competitive Outlook

The artificial biological valve market is demonstrating robust expansion, backed by increased incidence of valvular heart diseases among aging populations and an accelerated adoption of minimally invasive treatment options. Strategic investments from medtech leaders, coupled with the development of advanced materials and precise delivery mechanisms, are reshaping the competitive environment. The sector continues to attract new entrants aiming to address the unmet needs of both routine and complex cardiac interventions. Consolidation among established firms and rise of specialist innovators signal a dynamic ecosystem where partnerships and R&D drive market leadership.

Scope & Segmentation of the Artificial Biological Valve Market

This research report provides a detailed analysis by key segmentations and regional coverage. The examination of diverse categories equips executives to align offerings with evolving clinical and operational priorities.

  • Tissue Material: Homograft options include cryopreserved and decellularized valves; Xenograft options utilize bovine and porcine sources for consistent and scalable supply.
  • Implantation Method: Surgical approaches include minimally invasive and open replacement techniques; transcatheter procedures use transaortic, transapical, and transfemoral access points.
  • Valve Position: Primary focus remains on aortic implants, with rising research into mitral, pulmonary, and tricuspid positions to address a broader spectrum of cardiac conditions.
  • End User: Includes ambulatory surgery centers for rapid procedures, hospitals for comprehensive care, and specialized clinics delivering tailored patient solutions.
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), EMEA (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Technologies: Advanced decellularization, three-dimensional printing for patient-specific grafts, minimally invasive and transcatheter delivery, and real-time imaging guidance for precision placement.
  • Notable Market Players: Leading and emerging companies analyzed include Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, MicroPort Scientific Corporation, CryoLife, Inc., JenaValve Technology, Inc., Hangzhou Venus MedTech Co., Ltd., and 4C Medical Technologies, Inc.

Key Takeaways for Decision-Makers

  • Breakthroughs in biomaterials and patient-specific engineering enhance compatibility and device longevity.
  • Growth in minimally invasive and transcatheter procedures is prompting multidisciplinary teams to update protocols and broaden treatment access.
  • Regulatory harmonization and expedited pathways are fostering a more agile market for innovative devices, with strong post-market surveillance balancing approval speed.
  • Segmented demand highlights the importance of aligning development and marketing with specific clinical scenarios, implantation methods, and end user requirements.
  • Partnerships with digital health platforms and contract research organizations support remote monitoring, real-world data generation, and care pathway optimization.

Tariff Impact: Navigating Trade Disruptions

The introduction of United States tariffs in 2025 affects artificial biological valve supply chains, with duties on key bovine and porcine materials prompting manufacturers to reevaluate sourcing and production networks. Strategic responses include nearshoring, supplier diversification, and value-based contracting to ease price pressures and ensure consistent material access. Heightened regulatory engagement aims to secure tariff exemptions, underlining broader concerns over patient access and system affordability.

Methodology & Data Sources

This report is founded on rigorous primary research, including interviews with clinical and operational stakeholders, and comprehensive secondary research such as peer-reviewed journals and regulatory data. Quantitative data triangulation and qualitative analysis ensure the integrity and relevance of all strategic insights presented.

Why This Report Matters

  • Enables senior executives to identify emerging opportunities and mitigate risks arising from regulatory or supply-chain shifts.
  • Supplies targeted recommendations to bolster innovation, optimize sourcing, and refine product strategies for diverse healthcare settings.
  • Delivers an in-depth competitive analysis to inform partnership, investment, and expansion decisions in a rapidly evolving market.

Conclusion

The artificial biological valve market is shaped by technology, regulation, and evolving patient needs. Strategic agility and informed decision-making will define sustainable competitive advantage in this complex global environment.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising integration of transcatheter bioprosthetic valve procedures for high-risk cardiovascular patients
5.2. Development of next-generation bovine pericardial valves with novel anti-calcification surface treatments
5.3. Expansion of 3D printing technologies for customizing patient-specific biological heart valve implants
5.4. Increased focus on polymer-based scaffold structures to improve long-term valve performance and biocompatibility
5.5. Strategic partnerships between medical device companies and research institutes to accelerate valve innovation timelines
5.6. Growing regulatory approvals of next-generation valves with enhanced hemodynamics and reduced thrombogenic profiles
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Artificial Biological Valve Market, by Tissue Material
8.1. Introduction
8.2. Homograft
8.2.1. Cryopreserved
8.2.2. Decellularized
8.3. Xenograft
8.3.1. Bovine
8.3.2. Porcine
9. Artificial Biological Valve Market, by Implantation Method
9.1. Introduction
9.2. Surgical
9.2.1. Minimally Invasive
9.2.2. Open Replacement
9.3. Transcatheter
9.3.1. Transaortic
9.3.2. Transapical
9.3.3. Transfemoral
10. Artificial Biological Valve Market, by Valve Position
10.1. Introduction
10.2. Aortic
10.3. Mitral
10.4. Pulmonary
10.5. Tricuspid
11. Artificial Biological Valve Market, by End User
11.1. Introduction
11.2. Ambulatory Surgery Centers
11.3. Hospitals
11.4. Specialized Clinics
12. Americas Artificial Biological Valve Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Artificial Biological Valve Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Artificial Biological Valve Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Edwards Lifesciences Corporation
15.3.2. Medtronic plc
15.3.3. Abbott Laboratories
15.3.4. Boston Scientific Corporation
15.3.5. LivaNova PLC
15.3.6. MicroPort Scientific Corporation
15.3.7. CryoLife, Inc.
15.3.8. JenaValve Technology, Inc.
15.3.9. Hangzhou Venus MedTech Co., Ltd.
15.3.10. 4C Medical Technologies, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ARTIFICIAL BIOLOGICAL VALVE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ARTIFICIAL BIOLOGICAL VALVE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ARTIFICIAL BIOLOGICAL VALVE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. ARTIFICIAL BIOLOGICAL VALVE MARKET: RESEARCHAI
FIGURE 24. ARTIFICIAL BIOLOGICAL VALVE MARKET: RESEARCHSTATISTICS
FIGURE 25. ARTIFICIAL BIOLOGICAL VALVE MARKET: RESEARCHCONTACTS
FIGURE 26. ARTIFICIAL BIOLOGICAL VALVE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ARTIFICIAL BIOLOGICAL VALVE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY CRYOPRESERVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY CRYOPRESERVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY DECELLULARIZED, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY DECELLULARIZED, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY BOVINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY BOVINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY PORCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY PORCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY OPEN REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY OPEN REPLACEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSAORTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSAORTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSAPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSAPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSFEMORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSFEMORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY AORTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY AORTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY MITRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY MITRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY PULMONARY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY PULMONARY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRICUSPID, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRICUSPID, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 101. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 102. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 103. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 104. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 105. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 106. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 107. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 108. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 109. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 110. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 111. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 112. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 113. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 114. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 115. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. CANADA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 118. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 119. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 120. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 121. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 122. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 123. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 124. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 125. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 126. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 127. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 128. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 129. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 130. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 131. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. MEXICO ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 200. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 201. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 202. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 203. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 204. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 205. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 206. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 207. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 208. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 209. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 210. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 211. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 212. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 213. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. GERMANY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 216. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 217. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 218. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 219. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 220. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 221. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 222. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 223. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 224. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 225. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 226. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 227. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 228. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 229. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. FRANCE ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 248. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 249. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 250. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 251. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 252. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 253. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 254. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 255. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 256. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 257. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 258. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 259. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 260. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 261. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. ITALY ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 264. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 265. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 266. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 267. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 268. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 269. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 270. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 271. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 272. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 273. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 274. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 275. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 276. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 277. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. SPAIN ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY IMPLANTATION METHOD, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TRANSCATHETER, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY VALVE POSITION, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY TISSUE MATERIAL, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY HOMOGRAFT, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA ARTIFICIAL BIOLOGICAL VALVE MARKET SIZE, BY XENOGRAFT, 20

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Artificial Biological Valve market report include:
  • Edwards Lifesciences Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • LivaNova PLC
  • MicroPort Scientific Corporation
  • CryoLife, Inc.
  • JenaValve Technology, Inc.
  • Hangzhou Venus MedTech Co., Ltd.
  • 4C Medical Technologies, Inc.

Related Topics

Related Reports

Xenograft tissue-based Implant Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application - Product Image

Xenograft tissue-based Implant Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application

  • Report
  • 92 Pages
  • Global
From
Artificial Bone Market - Global Forecast 2025-2030 - Product Image

Artificial Bone Market - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Dental Bone Graft Substitutes: Market Share, and Growth Analysis by Product Type (Ceramics, Polymers, Allografts, Xenografts), Application, End User, Technology - Product Image

Dental Bone Graft Substitutes: Market Share, and Growth Analysis by Product Type (Ceramics, Polymers, Allografts, Xenografts), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Bioprosthetics Market - Global Forecast 2025-2030 - Product Image

Bioprosthetics Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Biological Implants - Global Strategic Business Report - Product Image

Biological Implants - Global Strategic Business Report

  • Report
  • 281 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.